Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aranesp for Anemia in Prostate Cancer
NCT00245895Phase 2Completed
- Sponsor
- University of Washington
- Start
- Apr 2003
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of darbepoetin alfa in anemia, sponsored by University of Washington. Primary endpoint: Proportion of patients achieving Hemoglobin greater than or equal to 12.5 g/dL. Started Apr 2003; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00245895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245895.